Description
N-(Iodoacetamido)-doxorubicin is a modified doxorubicin derivative featuring an iodoacetamido moiety. This reactive iodoacetamido group enables covalent conjugation with thiol and amine groups, while the doxorubicin core retains its potent anthracycline-based antineoplastic activity, commonly used in cancer research.
Applications
N-(Iodoacetamido)-doxorubicin is employed in targeted drug delivery, antibody-drug conjugates (ADCs), and cancer research. Its iodoacetamido group allows for site-specific conjugation with biomolecules, enhancing targeted therapeutic applications and facilitating the development of novel chemotherapeutic agents.